AI for Drug Discovery — A Leadership Masterclass for Life Sciences Professionals
Fri, 03 Jul
|A virtual series organized by Ernst & Young
Where Scientific Innovation Meets Leadership Excellence
Time & Location
03 Jul 2026, 4:00 pm – 5:00 pm
A virtual series organized by Ernst & Young
About the event
A peak into the Drug Discovery process and what is the role of AI in accelerating it
Abstract
As we enter 2026, AI in drug discovery has moved from the "innovation lab" to the "C-suite agenda. As it had to move up in value chain! Many use cases like drug candidate screening, drug design, protein interactions, ADME-profiling, Toxicity assessments, documentation, experimentation design, QbD, have been worked upon and now we have AI‑discovered/AI‑designed drug. Meanwhile, the compliance and regulations have been very intense in this domain!
Since I was involved in Pharma for 30+ years, I got invited by EY (Ernst & Young) to become a part of their Industry talk series under their AI Varsity initiative. I will be covering 4 aspects for participants to learn from
a. Business
b. Science